OSLO,
Norway, Aug. 18, 2023 /PRNewswire/
-- Reference is made to the stock exchange announcement
published earlier today, on 18 August
2023 by Navamedic ASA (the "Company" or "Navamedic"),
regarding the board of directors' resolution to increase the
Company's share capital with NOK
92,500 by the issuance of 125,000 new shares, in order to
facilitate the settlement of exercise of 125,000 share options in
the Company.
The following primary insiders have today exercised share
options:
Kathrine Gamborg Andreassen, CEO
of Navamedic, has today, on August 18
2023, exercised 25,000 share options in the Company under her
options agreement from 2020 and subscribed for 25,000 new shares in
the Company. Following the option exercise and subscription of the
new shares, Kathrine Gamborg
Andreassen holds 691 668 shares and 280,000 options in the
Company.
Lars Hjarrand, CFO of Navamedic, has today, on August 18 2023, exercised 25,000 share options in
the Company under his option agreements from 2019 and subscribed
for 25,000 new shares in the Company. Following the option exercise
and subscription of the new shares, Lars Hjarrand holds 285,882
shares and 250,000 options in the Company.
Astrid Bratvedt, CSO of Navamedic, has today, on August 18 2023, exercised 75,000 share options in
the Company under her option agreements from 2020 and subscribed
for 75,000 new shares in the Company. Following the option exercise
and subscription of the new shares, Astrid Bratvedt holds 602,000
shares and 200,000 options in the Company.
Please refer to the attached notification of trading for further
details.
This information is subject of the disclosure requirements
pursuant to section 5-12 of the Norwegian Securities Trading
Act.
The following files are available for download:
|
https://mb.cision.com/Main/17619/3819752/2235769.pdf
|
Notification of trade
by primary insider - Navamedic ASA
|
View original
content:https://www.prnewswire.co.uk/news-releases/navamedic-asa--mandatory-notification-of-trade-by-primary-insider-301904474.html